|
Oct 1
|
These Stocks Are Moving the Most Today: APA, Northrop, Boeing, Super Micro, HP Inc., Tesla, Li Auto, CVS, Ford, and More
|
|
Oct 1
|
IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO
|
|
Oct 1
|
Top 1% Biotech, IGM Biosciences, Plummets On Scrapped Drug, C-Suite Makeover
|
|
Oct 1
|
IGM Biosciences Stock Drops Sharply on ‘Pipeline Transformation’ to Autoimmune Diseases
|
|
Oct 1
|
IGM lays off staff in autoimmune pivot; Metsera ramps up obesity drug supply
|
|
Sep 30
|
IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity
|
|
Sep 27
|
While shareholders of IGM Biosciences (NASDAQ:IGMS) are in the black over 1 year, those who bought a week ago aren't so fortunate
|
|
Jul 12
|
IGM Biosciences (IGMS) Soars 32.7%: Is Further Upside Left in the Stock?
|
|
May 10
|
IGM Biosciences Inc (IGMS) Q1 2024 Earnings: Aligns with EPS Projections Amidst Clinical ...
|
|
May 8
|
IGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Misses Revenue Estimates
|
|
May 8
|
IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
|
|
May 7
|
IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference
|
|
May 6
|
Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
|
May 3
|
IGM Biosciences, Inc. (IGMS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Apr 30
|
IGM Biosciences (IGMS) Upgraded to Buy: What Does It Mean for the Stock?
|
|
Apr 19
|
IGM Biosciences Insiders Placed Bullish Bets Worth US$992.2k
|
|
Apr 17
|
IGM Biosciences Announces Refocusing of Sanofi Collaboration
|
|
Apr 10
|
IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum
|
|
Mar 9
|
IGM Biosciences Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
|
|
Mar 7
|
IGM Biosciences, Inc. (IGMS) Reports Q4 Loss, Lags Revenue Estimates
|